Matthew LaRouche

Process Development Scientist II at Cook MyoSite
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 100 - 200 Employee
    • Process Development Scientist II
      • Feb 2023 - Present

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Product Engineer
      • Jun 2020 - Oct 2022

      Directed the buildout of a GMP pharmaceutical cleanroom while managing cell processing operations engineering T-cells to identify and eliminate tumors. Managed and assisted teams of contractors in the development of an interdepartmental process quality management system. Assisted in the establishment and day to day operations of the company’s global cell therapy operations in the U.S., Japan, Thailand, Israel, Singapore, and Croatia. Improved manufacturing methods to enhance system-wide efficiency and quality at six global facilities using data driven analytics and a solid understanding of good manufacturing practices.

    • Presidential Fellow
      • Aug 2016 - May 2020

      Undergraduate Research Assistant. Program for Undergraduate Research grant recipient and student researcher. Undergraduate Research Assistant. Program for Undergraduate Research grant recipient and student researcher.

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Professional Research Assistant
      • Jun 2019 - Aug 2019

      Advanced immuno-oncology research and development for autologous drug products. Designed and implemented experimental protocols optimizing the small and large-scale isolation of Peripheral Blood Mononuclear Cells to maximize the effectiveness of cell-based immunotherapy. Results were applied to multi-national human clinical trials evaluating the safety and efficacy of the TBX-3400 drug product. Advanced immuno-oncology research and development for autologous drug products. Designed and implemented experimental protocols optimizing the small and large-scale isolation of Peripheral Blood Mononuclear Cells to maximize the effectiveness of cell-based immunotherapy. Results were applied to multi-national human clinical trials evaluating the safety and efficacy of the TBX-3400 drug product.

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Biomedical Research Intern
      • Jun 2018 - Aug 2018

      Conducted research investigating the use of T-Cells and Hematopoietic Stem Cells to treat cancer and infectious diseases, including Stage III and IV melanoma. Performed bacterial plasmid induction for protein creation, large scale bacterial fermentation, protein purification, passed tissue cultures, and managed cryogenic master cell banks. Conducted research investigating the use of T-Cells and Hematopoietic Stem Cells to treat cancer and infectious diseases, including Stage III and IV melanoma. Performed bacterial plasmid induction for protein creation, large scale bacterial fermentation, protein purification, passed tissue cultures, and managed cryogenic master cell banks.

Education

  • Colorado State University
    Master of Engineering - MEng, Biomedical Engineering
    2022 - 2024
  • Bucknell University
    Bachelor of Science - BS, Biomedical Engineering
    2016 - 2020

Community

You need to have a working account to view this content. Click here to join now